1873 related articles for article (PubMed ID: 30352955)
1. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary management of mammary Paget's disease: recommendations to optimize oncological and aesthetic outcomes.
Franceschini G; Mason EJ; Di Leone A; Scardina L; Masetti R
Ann Ital Chir; 2022; 93():481-482. PubMed ID: 36196555
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer.
Man VC; Cheung PS
Hong Kong Med J; 2017 Jun; 23(3):251-7. PubMed ID: 28484080
[TBL] [Abstract][Full Text] [Related]
5. The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy.
Mazouni C; Naveau A; Kane A; Dunant A; Garbay JR; Leymarie N; Sarfati B; Delaloge S; Rimareix F
Breast; 2013 Dec; 22(6):1189-93. PubMed ID: 24054903
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy in breast-conserving surgery - Consequences on margin status and excision volumes: A nationwide pathology study.
Volders JH; Haloua MH; Krekel NM; Negenborn VL; Barbé E; Sietses C; Jóźwiak K; Meijer S; van den Tol MP;
Eur J Surg Oncol; 2016 Jul; 42(7):986-93. PubMed ID: 27211343
[TBL] [Abstract][Full Text] [Related]
7. 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET.
Nakamura S; Kenjo H; Nishio T; Kazama T; Do O; Suzuki K
Breast Cancer; 2001; 8(4):351-4. PubMed ID: 11791129
[TBL] [Abstract][Full Text] [Related]
8. Close/positive margins after breast-conserving therapy: additional resection or no resection?
Wood WC
Breast; 2013 Aug; 22 Suppl 2():S115-7. PubMed ID: 24074771
[TBL] [Abstract][Full Text] [Related]
9. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
Boughey JC; McCall LM; Ballman KV; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Flippo-Morton T; Hunt KK
Ann Surg; 2014 Oct; 260(4):608-14; discussion 614-6. PubMed ID: 25203877
[TBL] [Abstract][Full Text] [Related]
10. Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.
Volders JH; Negenborn VL; Spronk PE; Krekel NMA; Schoonmade LJ; Meijer S; Rubio IT; van den Tol MP
Breast Cancer Res Treat; 2018 Feb; 168(1):1-12. PubMed ID: 29214416
[TBL] [Abstract][Full Text] [Related]
11. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
12. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
13. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
[TBL] [Abstract][Full Text] [Related]
14. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy in the treatment of breast cancer.
Redden MH; Fuhrman GM
Surg Clin North Am; 2013 Apr; 93(2):493-9. PubMed ID: 23464698
[TBL] [Abstract][Full Text] [Related]
16. Breast-conserving surgery in early-stage breast cancer (indications, local recurrences, survival, cosmetic results).
Mitov FS; Molov VV
Folia Med (Plovdiv); 2006; 48(1):23-30. PubMed ID: 16918051
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
[TBL] [Abstract][Full Text] [Related]
18. Breast conservative surgery for operable invasive ductal carcinoma after neoadjuvant chemotherapy or hormonal therapy- a challenge for breast surgeon: a review based on literature and experience.
Bobin JY; Al-Khaledi K; Ahmad J
Gulf J Oncolog; 2011 Jan; (9):45-51. PubMed ID: 21177208
[TBL] [Abstract][Full Text] [Related]
19. Current and future role of neoadjuvant therapy for breast cancer.
Untch M; Konecny GE; Paepke S; von Minckwitz G
Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
[TBL] [Abstract][Full Text] [Related]
20. Oncoplastic techniques extend breast-conserving surgery to patients with neoadjuvant chemotherapy response unfit for conventional techniques.
Regaño S; Hernanz F; Ortega E; Redondo-Figuero C; Gómez-Fleitas M
World J Surg; 2009 Oct; 33(10):2082-6. PubMed ID: 19657577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
